A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a sign ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

TUESDAY, Feb. 18, 2025 (HealthDay News) -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in disadvantaged neighborhoods of London, researchers report.

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.